• 1
    Howe, H. L., P. A. Wingo, M. J. Thun, L. A. Ries, H. M. Rosenberg, E. G. Feigal and B. K. Edwards (2001) Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. J. Natl Cancer Inst. 93, 824842.
  • 2
    Slaper, H., G. J. Velders, J. S. Daniel, F. R. De Gruijl and J. C. Van Der Leun (1996) Estimates of ozone depletion and skin cancer incidence to examine the Vienna Convention achievements. Nature 384, 256258.
  • 3
    Urbach, F. (1997) Ultraviolet radiation and skin cancer of humans. J. Photochem. Photobiol. B, Biol. 40, 37.
  • 4
    Setlow, R. B., E. Grist, K. Thompson and A. D. Woodhead (1993) Wavelengths effective in induction of malignant melanoma. Proc. Natl Acad. Sci. USA 90, 66666670.
  • 5
    Urbach, F. (1991) Potential health effects of climatic change: Effects of increased ultraviolet radiation on man. Environ. Health Perspect. 96, 175176.
  • 6
    Van Der Leun, J. C., F. R. De Gruijl, M. Tevini and R. C. Worrest (1993) Ultraviolet carcinogenesis: Environmental effects of ozone depletion. Recent Results Cancer Res. 128, 263267.
  • 7
    Boyle, J., R. M. MacKie, J. D. Briggs, B. J. Junor and T. C. Aitchison (1984) Cancer, warts, and sunshine in renal transplant patients. A case–control study. Lancet 1, 702705.
  • 8
    Marshall, V. (1974) Premalignant and malignant skin tumours in immunosuppressed patients. Transplantation 17, 272275.
  • 9
    O’Donovan, P., C. M. Perrett, X. Zhang, B. Montaner, Y. Z. Xu, C. A. Harwood, J. M. McGregor, S. L. Walker, F. Hanaoka and P. Karran (2005) Azathioprine and UVA light generate mutagenic oxidative DNA damage. Science 309, 18711874.
  • 10
    Norbury, K. C. and M. L. Kripke (1978) Ultraviolet carcinogenesis in T-cell-depleted mice. J. Natl Cancer Inst. 61, 917921.
  • 11
    Kripke, M. L. (1974) Antigenicity of murine skin tumors induced by ultraviolet light. J. Natl Cancer Inst. 53, 13331336.
  • 12
    Kripke, M. L. (1977) Ultraviolet radiation and tumor immunity. J. Reticuloendothel. Soc. 22, 217222.
  • 13
    Kripke, M. L. (1977) Latency, histology, and antigenicity of tumors induced by ultraviolet light in three inbred mouse strains. Cancer Res. 37, 13951400.
  • 14
    Kripke, M. L. and M. S. Fisher (1976) Immunologic responses of the autochthonous host against tumors induced by ultraviolet light. Adv. Exp. Med. Biol. 66, 445449.
  • 15
    Kripke, M. L. and M. S. Fisher (1978) Immunologic aspects of tumor induction by ultraviolet radiation. Natl. Cancer Inst. Monogr. 50, 179183.
  • 16
    Kripke, M. L., R. M. Thorn, P. H. Lill, C. I. Civin, N. H. Pazmino and M. S. Fisher (1979) Further characterization of immunological unresponsiveness induced in mice by ultraviolet radiation. Growth and induction of nonultraviolet-induced tumors in ultraviolet-irradiated mice. Transplantation 28, 212217.
  • 17
    Fisher, M. S. and M. L. Kripke (1978) Further studies on the tumor-specific suppressor cells induced by ultraviolet radiation. J. Immunol. 121, 11391144.
  • 18
    Fisher, M. S. and M. L. Kripke (1982) Suppressor T lymphocytes control the development of primary skin cancers in ultraviolet-irradiated mice. Science 216, 11331134.
  • 19
    Simon, J. C., H. Hara, R. W. Denfeld and S. Martin (2002) UVB-irradiated dendritic cells induce nonproliferating, regulatory type T cells. Skin Pharmacol. Appl. Skin Physiol. 15, 330334.
  • 20
    Schroder, J. M., K. Reich, K. Kabashima, F. T. Liu, N. Romani, M. Metz, A. Kerstan, P. H. Lee, K. Loser, M. P. Schon, M. Maurer, P. Stoitzner, S. Beissert, Y. Tokura and R. L. Gallo (2006) Who is really in control of skin immunity under physiological circumstances—Lymphocytes, dendritic cells or keratinocytes? Exp. Dermatol. 15, 913929.
  • 21
    Beissert, S. and R. D. Granstein (1996) UV-induced cutaneous photobiology. Crit. Rev. Biochem. Mol. Biol. 31, 381404.
  • 22
    Grabbe, S., S. Bruvers, R. L. Gallo, T. L. Knisely, R. Nazareno and R. D. Granstein (1991) Tumor antigen presentation by murine epidermal cells. J. Immunol. 146, 36563661.
  • 23
    Grabbe, S., S. Bruvers, A. M. Lindgren, J. Hosoi, K. C. Tan and R. D. Granstein (1992) Tumor antigen presentation by epidermal antigen-presenting cells in the mouse: Modulation by granulocyte-macrophage colony-stimulating factor, tumor necrosis factor alpha, and ultraviolet radiation. J. Leukoc. Biol. 52, 209217.
  • 24
    Hodge, J. W., S. Abrams, J. Schlom and J. A. Kantor (1994) Induction of antitumor immunity by recombinant vaccinia viruses expressing B7-1 or B7-2 costimulatory molecules. Cancer Res. 54, 55525555.
  • 25
    Lenschow, D. J., T. L. Walunas and J. A. Bluestone (1996) CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14, 233258.
  • 26
    Tang, A., T. A. Judge, B. J. Nickoloff and L. A. Turka (1996) Suppression of murine allergic contact dermatitis by CTLA4Ig. Tolerance induction of Th2 responses requires additional blockade of CD40-ligand. J. Immunol. 157, 117125.
  • 27
    Krummel, M. F. and J. P. Allison (1995) CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J. Exp. Med. 182, 459465.
  • 28
    Kuchroo, V. K., M. P. Das, J. A. Brown, A. M. Ranger, S. S. Zamvil, R. A. Sobel, H. L. Weiner, N. Nabavi and L. H. Glimcher (1995) B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy. Cell 80, 707718.
  • 29
    Thompson, C. B. (1995) Distinct roles for the costimulatory ligands B7-1 and B7-2 in T helper cell differentiation? Cell 81, 979982.
  • 30
    Boussiotis, V. A., J. G. Gribben, G. J. Freeman and L. M. Nadler (1994) Blockade of the CD28 co-stimulatory pathway: A means to induce tolerance. Curr. Opin. Immunol. 6, 797807.
  • 31
    Beissert, S., J. A. Bluestone, I. Mindt, M. Voskort, D. Metze, A. Mehling, T. A. Luger, T. Schwarz and S. Grabbe (1999) Reduced ultraviolet-induced carcinogenesis in mice with a functional disruption in B7-mediated costimulation. J. Immunol. 163, 67256731.
  • 32
    Loser, K., A. Scherer, M. B. Krummen, G. Varga, T. Higuchi, T. Schwarz, A. H. Sharpe, S. Grabbe, J. A. Bluestone and S. Beissert (2005) An important role of CD80/CD86-CTLA-4 signaling during photocarcinogenesis in mice. J. Immunol. 174, 52985305.
  • 33
    Kim, J., R. L. Modlin, R. L. Moy, S. M. Dubinett, T. McHugh, B. J. Nickoloff and K. Uyemura (1995) IL-10 production in cutaneous basal and squamous cell carcinomas. A mechanism for evading the local T cell immune response. J. Immunol. 155, 22402247.
  • 34
    Dummer, W., B. C. Bastian, N. Ernst, C. Schanzle, A. Schwaaf and E. B. Brocker (1996) Interleukin-10 production in malignant melanoma: Preferential detection of IL-10-secreting tumor cells in metastatic lesions. Int. J. Cancer 66, 607610.
  • 35
    Dummer, W., J. C. Becker, A. Schwaaf, M. Leverkus, T. Moll and E. B. Brocker (1995) Elevated serum levels of interleukin-10 in patients with metastatic malignant melanoma. Melanoma Res. 5, 6768.
  • 36
    Kruger-Krasagakes, S., K. Krasagakis, C. Garbe, E. Schmitt, C. Huls, T. Blankenstein and T. Diamantstein (1994) Expression of interleukin 10 in human melanoma. Br. J. Cancer 70, 11821185.
  • 37
    Richter, G., S. Kruger-Krasagakes, G. Hein, C. Huls, E. Schmitt, T. Diamantstein and T. Blankenstein (1993) Interleukin 10 transfected into Chinese hamster ovary cells prevents tumor growth and macrophage infiltration. Cancer Res. 53, 41344137.
  • 38
    Ding, W., S. Beissert, L. Deng, E. Miranda, C. Cassetty, K. Seiffert, K. L. Campton, Z. Yan, G. F. Murphy, J. A. Bluestone and R. D. Granstein (2003) Altered cutaneous immune parameters in transgenic mice overexpressing viral IL-10 in the epidermis. J. Clin. Invest. 111, 19231931.
  • 39
    Loser, K., J. Apelt, M. Voskort, M. Mohaupt, S. Balkow, T. Schwarz, S. Grabbe and S. Beissert (2007) IL-10 controls ultraviolet-induced carcinogenesis in mice. J. Immunol. 179, 365371.
  • 40
    Loser, K., W. Hansen, J. Apelt, S. Balkow, J. Buer and S. Beissert (2005) In vitro-generated regulatory T cells induced by Foxp3-retrovirus infection control murine contact allergy and systemic autoimmunity. Gene Ther. 12, 12941304.
  • 41
    Ziegler, S. F. (2006) FOXP3: Of mice and men. Annu. Rev. Immunol. 24, 209226.
  • 42
    Nishigori, C., D. B. Yarosh, S. E. Ullrich, A. A. Vink, C. D. Bucana, L. Roza and M. L. Kripke (1996) Evidence that DNA damage triggers interleukin 10 cytokine production in UV-irradiated murine keratinocytes. Proc. Natl Acad. Sci. USA 93, 1035410359.
  • 43
    Mohammad, T., H. Morrison and H. HogenEsch (1999) Urocanic acid photochemistry and photobiology. Photochem. Photobiol. 69, 115135.
  • 44
    Reeve, V. E., G. E. Greenoak, P. J. Canfield, C. Boehm-Wilcox and C. H. Gallagher (1989) Topical urocanic acid enhances UV-induced tumour yield and malignancy in the hairless mouse. Photochem. Photobiol. 49, 459464.
  • 45
    Beissert, S., T. Mohammad, H. Torri, A. Lonati, Z. Yan, H. Morrison and R. D. Granstein (1997) Regulation of tumor antigen presentation by urocanic acid. J. Immunol. 159, 9296.
  • 46
    Beissert, S., D. Ruhlemann, T. Mohammad, S. Grabbe, A. El-Ghorr, M. Norval, H. Morrison, R. D. Granstein and T. Schwarz (2001) IL-12 prevents the inhibitory effects of cis-urocanic acid on tumor antigen presentation by Langerhans cells: Implications for photocarcinogenesis. J. Immunol. 167, 62326238.
  • 47
    Willimsky, G. and T. Blankenstein (2005) Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance. Nature 437, 141146.
  • 48
    Thien, C. B. and W. Y. Langdon (2001) Cbl: Many adaptations to regulate protein tyrosine kinases. Nat. Rev. Mol. Cell Biol. 2, 294307.
  • 49
    Bachmaier, K., C. Krawczyk, I. Kozieradzki, Y. Y. Kong, T. Sasaki, A. Oliveira-dos-Santos, S. Mariathasan, D. Bouchard, A. Wakeham, A. Itie, J. Le, P. S. Ohashi, I. Sarosi, H. Nishina, S. Lipkowitz and J. M. Penninger (2000) Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b. Nature 403, 211216.
  • 50
    Chiang, Y. J., H. K. Kole, K. Brown, M. Naramura, S. Fukuhara, R. J. Hu, I. K. Jang, J. S. Gutkind, E. Shevach and H. Gu (2000) Cbl-b regulates the CD28 dependence of T-cell activation. Nature 403, 216220.
  • 51
    Wohlfert, E. A., M. K. Callahan and R. B. Clark (2004) Resistance to CD4+CD25+ regulatory T cells and TGF-beta in Cbl-b/ mice. J. Immunol. 173, 10591065.
  • 52
    Chiang, J. Y., I. K. Jang, R. Hodes and H. Gu (2007) Ablation of Cbl-b provides protection against transplanted and spontaneous tumors. J. Clin. Invest. 117, 10291036.
  • 53
    Loeser, S., K. Loser, M. S. Bijker, M. Rangachari, S. H. Van Der Burg, T. Wada, S. Beissert, C. J. Melief and J. M. Penninger (2007) Spontaneous tumor rejection by cbl-b-deficient CD8+ T cells. J. Exp. Med. 204, 879891.
  • 54
    Beissert, S. and T. Schwarz (1999) Mechanisms involved in ultraviolet light-induced immunosuppression. J. Investig. Dermatol. Symp. Proc. 4, 6164.
  • 55
    Loser, K., A. Mehling, S. Loeser, J. Apelt, A. Kuhn, S. Grabbe, T. Schwarz, J. M. Penninger and S. Beissert (2006) Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells. Nat. Med. 12, 13721379.
  • 56
    Jones, D. H., T. Nakashima, O. H. Sanchez, I. Kozieradzki, S. V. Komarova, I. Sarosi, S. Morony, E. Rubin, R. Sarao, C. V. Hojilla, V. Komnenovic, Y. Y. Kong, M. Schreiber, S. J. Dixon, S. M. Sims, R. Khokha, T. Wada and J. M. Penninger (2006) Regulation of cancer cell migration and bone metastasis by RANKL. Nature 440, 692696.